Talquetamab improves patient-reported symptoms and health-related quality of life in relapsed or refractory multiple myeloma: Results from the phase 1/2 MonumenTAL-1 study CANCER-AM CANCER SOC
New research programme to tackle childhood leukaemia at the Josep Carreras Institute July 24, 2025 New research programme to tackle childhood leukaemia at the Josep Carreras Institute
The Communication Unit of the Josep Carreras Institute is accredited as a Scientific Culture and Innovation Unit July 23, 2025 The Communication Unit of the Josep Carreras Institute is accredited as a Scientific Culture and Innovation Unit
Epigenetics on demand to tackle inflammatory diseases July 17, 2025 Epigenetics on demand to tackle inflammatory diseases
A new cell therapy for leukaemia shows high efficacy and safety in the laboratory July 07, 2025 A new cell therapy for leukaemia shows high efficacy and safety in the laboratory
A new drug developed in Spain shows great potential against Rett Syndrome June 26, 2025 A new drug developed in Spain shows great potential against Rett Syndrome
Dr. Mar Mallo: We recommend the use of Optical Genome Mapping in the diagnosis of leukaemia June 25, 2025 Dr. Mar Mallo: We recommend the use of Optical Genome Mapping in the diagnosis of leukaemia
The Innomed Awards highlight fifteen innovative biomedical projects in their second edition June 20, 2025 The Innomed Awards highlight fifteen innovative biomedical projects in their second edition